perfoliata spp. in 2/12 cases, cyathostomiasis in 6/12 cases and sand enteropathy in 1/12 cases. In three cases the cause of the colonic ulceration was not evident and the ulcerated areas were larger and more extensive than in those caused by parasitism or sand. Of the three cases of idiopathic ulceration, 2/3 cases were euthanised for reasons related to their behaviour, these horses were significantly more likely to have idiopathic colonic ulceration than those who were euthanised for other reasons (P = 0.01).
LAMENESS/ORTHOPAEDICS THE ANTI-INFLAMMATORY EFFECTS OF RESVERATROL IN EQUINE OSTEOARTHRITIS USING THE CARTILAGE EXPLANT MODEL
Reasons for performing study: Osteoarthritis is a common degenerative inflammatory disease of articulating joints in both horses and humans. There are currently no disease-modifying osteoarthritis drugs available for treatment. Resveratrol, a polyphenol found in red wine and grapevines, has been shown to have anti-inflammatory and antioxidant effects in multiple different studies in rats and mice.
Objectives: To assess the dose-response of resveratrol in an equine osteoarthritis cartilage explant model.
Study design: In vitro experiments.
Methods: Healthy cartilage (scored using the Osteoarthritis Research Society International scale) was harvested from the metacarpophalangeal joints of fresh cadaver limbs of six horses, which had been euthanised for reasons other than for this study. Cartilage samples were then cultured, and inflammatory osteoarthritic processes were induced in the samples using the pleiotropic cytokine interleukin (IL)-1b. Varying concentrations of resveratrol were added to the wells (1-300 μg/mL). End-point biomarkers of inflammation and cartilage breakdown were measured; nitric oxide and glycosaminoglycan (GAG) release. Histology using H&E staining was performed to qualitatively assess cell death. A dose-response was then determined for the inhibition of glycosaminoglycan release by resveratrol. Statistical analysis was performed using a paired ANOVA followed by multiple comparisons (Tukey).
Results: Resveratrol was found to significantly reduce IL-1b-stimulated GAG release at concentrations of 10 μg/mL (P>0.001). At concentrations of 1 and 100 μg/mL, resveratrol was found to have similar GAG release levels to IL-1b cultures alone, and at 300 μg/mL it was found to increase GAG release. Histology also showed that at 100 and 300 μg/mL doses, resveratrol was cytotoxic to chondrocytes. Nitric oxide production was also affected in a similar dose-dependent manner.
Conclusions: This is the first study to demonstrate the chondroprotective effects of resveratrol in an equine explant model.
Although it appears to have a narrow therapeutic window, resveratrol offers the potential to be developed into an efficacious treatment for equine osteoarthritis. Institute of Veterinary Science, University of Liverpool, Leahurst Campus, UK. E-mail: janders@liverpool.ac.uk Reasons for performing study: Articular pathology is common in horses causing loss of function and pain. These include osteoarthritis (OA), osteochondrosis (OC) and sepsis, the latter being life-threatening. However, diagnosis, staging, monitoring and accurate prognostication remains a challenge for practising veterinarians and there is therefore a need to identify reliable biomarkers for accurate and rapid diagnosis as well as gaining a greater understanding of the underlying pathogenesis. Synovial fluid (SF) is an integral articular component closely associated with other articular tissues that are primarily altered during joint pathologies. However, to date no studies have investigated the whole profile of metabolites of equine SF in different joint conditions.
Objectives: To define the metabolomic profile of SF samples obtained from equine joints affected by a variety of articular pathologies.
Study design: Prospective clinical study.
Methods: SF from equine joints (OA n = 6; OC n = 6; sepsis n = 7) was analysed using 1 H NMR (nuclear magnetic resonance) spectroscopy on a 600 MHz NMR Bruker Avance III spectrometer. Acquisition and processing were performed using Topsin 3.1 and IconNMR 4.6.7 with MetaboAnalyst 3.0 used to undertake univariate and multivariate statistical analyses. Metabolites were identified in 1 H NMR using inhouse libraries in conjunction with Chenomx software and confirmed utilising 2D 1 H 13 C NMR and CCPNMR Analysis software.
Results: A total of 25 metabolites were identified that are associated with various biosynthetic and degradation pathways. Cluster analysis identified 10 metabolites, including glucose and pyruvate, that allowed differentiation between nonseptic and septic joint pathologies. Metabolomic profiles of OA and OC did not differ.
Conclusions: This study demonstrates that NMR-led metabolomics is an effective technique for analysis of equine SF collected within a clinical veterinary environment. Furthermore, the metabolite profile of SF can discriminate between septic and nonseptic equine SF.
